GLP-1RAs may be beneficial for preservation of brain glucose metabolism and cognitive function in AD as supported by the results of two randomized, placebo-controlled trials in patients with mild-to-moderate AD dementia treated with the GLP-1RA liraglutide for 6 months and 12 months, respectively [29,30,31]
The GLP-1 receptor agonist market comprises both approved and investigational therapies
Avoiding daylight can substantially restrict education, work, travel, family activities and ordinary daily life
However, women in the study were younger and more likely to have obesity or depression
doi: 10.3390/ijerph13111503 Azizi et al., 2023
B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node